» Authors » P Hass

P Hass

Explore the profile of P Hass including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 381
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Deng B, Banu N, Malloy B, Hass P, Wang J, Cavacini L, et al.
Blood . 1998 Sep; 92(6):1981-8. PMID: 9731056
Thrombopoietin (TPO) is a hematopoietic growth factor that stimulates megakaryocytopoiesis and platelet production in vivo and promotes the development of identifiable megakaryocytes in vitro. We have developed a murine monoclonal...
12.
Fielder P, Hass P, Nagel M, Stefanich E, Widmer R, Bennett G, et al.
Blood . 1997 Apr; 89(8):2782-8. PMID: 9108396
Recent studies have shown that plasma thrombopoietin (TPO) levels appear to be directly regulated by platelet mass and that removal of plasma TPO by platelets via binding to the c-Mpl...
13.
Politoff A, STADTER R, Monson N, Hass P
Dementia . 1996 Mar; 7(2):69-75. PMID: 8866678
Down syndrome (DS) subjects develop Alzheimer disease (AD) histopathology before they develop dementia. We compared the resting and flash stimulated electroencephalogram (EEG) of nondemented adult DS and age-matched control subjects,...
14.
Politoff A, Monson N, STADTER R, Hass P
Dementia . 1995 May; 6(3):169-73. PMID: 7620530
We have shown that the response to flash stimulation of the occipital electroencephalogram (EEG) in Alzheimer disease (AD) patients is smaller than in normal subjects. To ascertain whether this is...
15.
Zeigler F, De Sauvage F, Widmer H, Keller G, Donahue C, Schreiber R, et al.
Blood . 1994 Dec; 84(12):4045-52. PMID: 7527664
Recently, the ligand for c-mpl has been identified and cloned. Initial studies of this molecule indicate that it is the platelet regulatory factor, thrombopoietin (TPO). Previous work has indicated that...
16.
Fischer S, Wolf G, Keilhoff G, Hass P
Eur J Pharmacol . 1993 Feb; 232(1):121-4. PMID: 7681405
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), an agonist of the non-N-methyl-D-aspartate (NMDA) subtype of the glutamate receptor, was used to imitate glutamate-induced brain injury. A single intracerebroventricular injection of AMPA (9 nmol; 1.7...
17.
Rothe F, Wolf G, Fischer S, Hass P, Keilhoff G, Abicht K
Neuroreport . 1993 Feb; 4(2):205-7. PMID: 8453060
To study the penetration of magnesium ions from blood into brain tissue, magnesium content in serum and hippocampus of normal and of excitotoxically affected rats was estimated after a single...
18.
Politoff A, Monson N, Hass P, Stadter R
Electroencephalogr Clin Neurophysiol . 1992 Jan; 82(1):45-52. PMID: 1370143
The power spectra of the photically activated occipital EEGs of 9 mildly to moderately demented probable Alzheimer disease (AD) patients (according to NINCDS-ADRDA criteria), 9 normal age-matched control and 27...
19.
Wolf G, Fischer S, Hass P, Abicht K, Keilhoff G
Neuroscience . 1991 Jan; 43(1):31-4. PMID: 1833668
Kainate, an agonist of a unique subclass of glutamate receptors (kainate receptor), was injected intracerebroventricularly in rats to induce convulsive reactions and hippocampal damage in order to model glutamate-mediated brain...
20.
Kunitake S, Young S, Chen G, Pullinger C, Zhu S, Pease R, et al.
J Biol Chem . 1990 Dec; 265(34):20739-46. PMID: 1701170
The low density lipoproteins (LDL) from patients with Tangier disease are enriched in triglycerides, 27% of LDL mass versus 7% for normal LDL. To study whether this unique LDL core...